Viewing Study NCT06508268


Ignite Creation Date: 2025-12-24 @ 5:54 PM
Ignite Modification Date: 2026-02-21 @ 10:12 PM
Study NCT ID: NCT06508268
Status: RECRUITING
Last Update Posted: 2024-07-18
First Post: 2024-05-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease
Sponsor: Hanze University of Applied Sciences Groningen
Organization:

Study Overview

Official Title: Language, Speech and Motor Function in Mild Cognitive Impairment Due to AD and Alzheimer's Disease
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this observational cross-sectional study is to explore the characteristics of language, speech, and motor function in persons with Mild Cognitive Impairment due to Alzheimer's disease ("MCI due to AD") and persons with mild and moderate Alzheimer's disease ("AD"). This study aims to:

* Explore motor, speech, and language functions in MCI due to AD and mild and moderate AD.
* Combine the characteristics of motor, language, and speech functions to gain more insight into the association of language, speech, and motor changes during MCI due to AD and mild and moderate AD.

Researchers will compare the outcomes to an age-matched control group without cognitive impairment.

Participants will undergo:

* Two motor function tests to assess gait and hand grip strength.
* Four language and speech function tests to assess spontaneous speech and verbal fluency..
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: